5-methyl-N-[3-(4-methyl-1,3-thiazol-5-yl)propyl]-4-(2-methyl-1,2,4-triazol-3-yl)pyrimidin-2-amine
C15H19N7S — CID 31125971
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-methyl-N-[3-(4-methyl-1,3-thiazol-5-yl)propyl]-4-(2-methyl-1,2,4-triazol-3-yl)pyrimidin-2-amine
5-methyl-N-[3-(4-methyl-1,3-thiazol-5-yl)propyl]-4-(2-methyl-1,2,4-triazol-3-yl)pyrimidin-2-amine (PubChem CID 31125971) has the molecular formula C15H19N7S and a molecular weight of 329.43 g/mol. Its IUPAC name is 5-methyl-N-[3-(4-methyl-1,3-thiazol-5-yl)propyl]-4-(2-methyl-1,2,4-triazol-3-yl)pyrimidin-2-amine.
Molecular Properties
| Compound Name | 5-methyl-N-[3-(4-methyl-1,3-thiazol-5-yl)propyl]-4-(2-methyl-1,2,4-triazol-3-yl)pyrimidin-2-amine |
|---|---|
| PubChem CID | 31125971 |
| Molecular Formula | C15H19N7S |
| Molecular Weight | 329.43 g/mol |
| Exact Mass | 329.14 |
| IUPAC Name | 5-methyl-N-[3-(4-methyl-1,3-thiazol-5-yl)propyl]-4-(2-methyl-1,2,4-triazol-3-yl)pyrimidin-2-amine |
| SMILES | Cc1cnc(NCCCc2scnc2C)nc1-c1ncnn1C |
| InChI | InChI=1S/C15H19N7S/c1-10-7-17-15(21-13(10)14-18-8-20-22(14)3)16-6-4-5-12-11(2)19-9-23-12/h7-9H,4-6H2,1-3H3,(H,16,17,21) |
| InChIKey | MLWCQOBTWHVXJB-UHFFFAOYSA-N |
| XLogP | 2.39 |
| TPSA | 81.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 329.43 |
| LogP ≤ 5 | 2.39 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 31125971 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.